Plasma C-MYC level manifesting as an indicator in progression of breast cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma C-MYC level manifesting as an indicator in progression of breast cancer
Authors
Keywords
-
Journal
Biomarkers in Medicine
Volume -, Issue -, Pages -
Publisher
Future Medicine Ltd
Online
2019-05-30
DOI
10.2217/bmm-2019-0073
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis
- (2018) Galileo A. Gonzalez-Conchas et al. CANCER TREATMENT REVIEWS
- Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients
- (2018) S. Valpione et al. EUROPEAN JOURNAL OF CANCER
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Quantification of cell-free DNA in blood plasma and DNA damage degree in lymphocytes to evaluate dysregulation of apoptosis in schizophrenia patients
- (2017) E.S. Ershova et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden
- (2017) Jagdeep Singh Bhangu et al. SURGICAL ONCOLOGY-OXFORD
- Characterization of the release and biological significance of cell-free DNA from breast cancer cell lines
- (2017) Wei Wang et al. Oncotarget
- Cell-free DNA detected by “liquid biopsy” as a potential prognostic biomarker in early breast cancer
- (2017) Roberta Maltoni et al. Oncotarget
- The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer
- (2017) Barbara Adamo et al. Oncotarget
- Characterization of the cell-free DNA released by cultured cancer cells
- (2016) Abel Jacobus Bronkhorst et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Follow the trace of death: methylation analysis of cell-free DNA for clinical applications in non-cancerous diseases
- (2016) Jörg Tost Epigenomics
- Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer
- (2016) Feifei Cheng et al. Oncotarget
- Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer
- (2016) Bo Ai et al. Oncotarget
- ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy
- (2016) Fei Ma et al. Oncotarget
- Single-stranded DNA library preparation uncovers the origin and diversity of ultrashort cell-free DNA in plasma
- (2016) Philip Burnham et al. Scientific Reports
- Numerical indices based on circulating tumor DNA for the evaluation of therapeutic response and disease progression in lung cancer patients
- (2016) Kikuya Kato et al. Scientific Reports
- Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease
- (2015) A Szpechcinski et al. BRITISH JOURNAL OF CANCER
- Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery
- (2015) Thomas Reinert et al. GUT
- Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer
- (2015) Tetsuyo Maeda et al. Medical Molecular Morphology
- Evaluation of an Optimal Cut-Off Point for the Ki-67 Index as a Prognostic Factor in Primary Breast Cancer: A Retrospective Study
- (2015) Rumiko Tashima et al. PLoS One
- Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes
- (2014) Silvia Darb-Esfahani et al. BMC CANCER
- Free circulating nucleic acids in plasma and serum as a novel approach to the use of internal controls in real time PCR based detection
- (2014) Ersin Karataylı et al. JOURNAL OF VIROLOGICAL METHODS
- Vascular Invasion as an Independent Prognostic Factor in Lymph Node Negative Invasive Breast Cancer
- (2013) Abbas Rezaianzadeh et al. Asian Pacific Journal of Cancer Prevention
- Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry
- (2013) E. C. Inwald et al. BREAST CANCER RESEARCH AND TREATMENT
- Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas
- (2013) Ming-Hua Luo et al. HUMAN PATHOLOGY
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients
- (2013) Minghui Zhang et al. Targeted Oncology
- Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis
- (2012) Andrea Malfettone et al. BMC CANCER
- Microvessel Density and Status of p53 Protein as Potential Prognostic Factors for Adjuvant Anthracycline Chemotherapy in Retrospective Analysis of Early Breast Cancer Patients Group
- (2012) Beata Biesaga et al. PATHOLOGY & ONCOLOGY RESEARCH
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- Emerging molecular biomarkers—blood-based strategies to detect and monitor cancer
- (2011) Samir M. Hanash et al. Nature Reviews Clinical Oncology
- CA 15-3: Uses and limitation as a biomarker for breast cancer
- (2010) Michael J. Duffy et al. CLINICA CHIMICA ACTA
- Ki67 in breast cancer: prognostic and predictive potential
- (2010) Rinat Yerushalmi et al. LANCET ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started